Bonnie S. Glisson, MD, on HPV-16+ Cancer: Study Results

2017 ESMO Congress
Tweet this page

Bonnie S. Glisson, MD, of The University of Texas MD Anderson Cancer Center, discusses a clinical trial on the combination of ISA101, an HPV-16 vaccine, and nivolumab for patients with incurable HPV-16+ cancer (Abstract 1136O).

Advertisement

Advertisement



Advertisement